BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16562370)

  • 21. Stereotactic body radiation therapy boost in locally advanced pancreatic cancer.
    Seo Y; Kim MS; Yoo S; Cho C; Yang K; Yoo H; Choi C; Lee D; Kim J; Kim MS; Kang H; Kim Y
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1456-61. PubMed ID: 19783379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supportive and palliative care of pancreatic cancer.
    Fazal S; Saif MW
    JOP; 2007 Mar; 8(2):240-53. PubMed ID: 17356251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined modality therapy for stage III non-small cell lung cancer.
    Stinchcombe TE; Fried D; Morris DE; Socinski MA
    Oncologist; 2006; 11(7):809-23. PubMed ID: 16880240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?
    Pisters PW; Evans DB
    Ann Surg; 2008 Aug; 248(2):152-3. PubMed ID: 18650622
    [No Abstract]   [Full Text] [Related]  

  • 25. Palliative treatment of pancreatic cancer.
    von Wichert G; Seufferlein T; Adler G
    J Dig Dis; 2008 Feb; 9(1):1-7. PubMed ID: 18251787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecularly targeted therapies for malignant gliomas: advances and challenges.
    Penas-Prado M; Gilbert MR
    Expert Rev Anticancer Ther; 2007 May; 7(5):641-61. PubMed ID: 17492929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteosarcoma treatment: state of the art.
    Ta HT; Dass CR; Choong PF; Dunstan DE
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):247-63. PubMed ID: 19214708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytokine-based and targeted therapy of metastatic renal cell carcinoma--a current analysis].
    Johannsen M; Ringsdorf M; Römer A; Loening SA; Roigas J
    Aktuelle Urol; 2007 Jan; 38(1):38-45. PubMed ID: 17290328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment for pancreatic cancer: current therapy and continued progress.
    Lockhart AC; Rothenberg ML; Berlin JD
    Gastroenterology; 2005 May; 128(6):1642-54. PubMed ID: 15887156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New systemic therapies in oncology].
    Zaman K; Ketterer N; Vulliémoz D; Stupp R; Leyvraz S
    Rev Med Suisse; 2005 May; 1(20):1361-2, 1364-5. PubMed ID: 15991629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Advances and Prospects for Multimodality Therapy in Pancreatic Cancer.
    Chadha AS; Khoo A; Aliru ML; Arora HK; Gunther JR; Krishnan S
    Semin Radiat Oncol; 2016 Oct; 26(4):320-37. PubMed ID: 27619253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cancer of the exocrine pancreas: where are we on treatment?].
    Huguier M; Billebaud T; Molkhou JM
    Gastroenterol Clin Biol; 1984 Jan; 8(1):3-6. PubMed ID: 6698338
    [No Abstract]   [Full Text] [Related]  

  • 34. Strategies to relieve immunosuppression in pancreatic cancer.
    Schnurr M; Duewell P; Bauer C; Rothenfusser S; Lauber K; Endres S; Kobold S
    Immunotherapy; 2015; 7(4):363-76. PubMed ID: 25917628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Insights Into the Biology and Treatment of Pancreatic Cancer.
    Mettu NB; Abbruzzese JL
    J Oncol Pract; 2016 Jan; 12(1):17-23. PubMed ID: 26759461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment strategy for pancreatic endocrine tumours].
    Mitry E; Rougier P
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S31-6. PubMed ID: 12704291
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recent advances in combined therapy with surgery for pancreatic cancer].
    Hosotani R
    Nihon Geka Hokan; 1995 Mar; 64(2):43-4. PubMed ID: 8678722
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic perspectives on pancreatic cancer.
    Sheahan AV; Phillips PA; Khachigian LM
    Curr Cancer Drug Targets; 2013 May; 13(4):400-10. PubMed ID: 23517597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the management of pancreatic cancer.
    Del Chiaro M; Sugawara T; Karam SD; Messersmith WA
    BMJ; 2023 Dec; 383():e073995. PubMed ID: 38164628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine in pancreatic cancer: Emerging combination therapies.
    Roth S; Hackert T
    EBioMedicine; 2019 Oct; 48():20-21. PubMed ID: 31590927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.